Suppr超能文献

用于保留乳头乳房切除术的多爱肤®胸罩。

Duoderm®-Bra for Nipple-Sparing Mastectomy.

作者信息

Dayicioglu Deniz, Trotta Rose, Agoris Corin, Kumar Ambuj

机构信息

From the *Division of Plastic Surgery, Department of Surgery, University of South Florida, Morsani College of Medicine; †University of South Florida, Morsani College of Medicine; and ‡Clinical and Translational Science Institute, University of South Florida, Morsani College of Medicine, Tampa, FL.

出版信息

Ann Plast Surg. 2016 Jun;76 Suppl 4:S280-5. doi: 10.1097/SAP.0000000000000753.

Abstract

BACKGROUND

Nipple-sparing mastectomy (NSM) with tissue expander reconstruction is a widely used technique that can produce aesthetically pleasing reconstruction results after mastectomy. Nipple position and healthy mastectomy flaps with good vascularity are important determinants of an adequate aesthetic final result. An initial high fill volume of the expander can produce a more natural breast mound appearance postoperatively. However, this can often lead to ischemia with loss of the nipple-areolar complex (NAC). Conversely, low intraoperative fill rates are conducive to enhanced tissue circulation and viability. But this may lead to poor skin envelope draping and nipple placement lower than desired. We have developed a new technique called "Duoderm®-bra" that brings together both mastectomy skin tissue health and aesthetic success with optimal nipple positioning. We hypothesized that with Duoderm®-bra, the NAC can be stabilized in the desired high position and ptosis can be reduced. We also hypothesized that by eliminating the need for acellular dermal matrix and intraoperative fill, "Duoderm®-bra" would decrease the rate of complications. The objective of this study was to evaluate the effects of using novel "Duoderm®-bra" technique in NSM.

METHODS

After an institutional review board approval, a retrospective chart review of 35 consecutive patients was done with 65 breasts undergoing NSM and tissue expander reconstruction by the same plastic surgeon. Patients in whom "Duoderm®-bra" was used were compared with patients without the "Duoderm®-bra." Patients with acellular dermal matrix were excluded. Age, ptosis grade, preoperative nipple to IMF ratio (R/L), tumor characteristics, mastectomy specimen weight (R/L), time from mastectomy to first fill, time from mastectomy to final fill, final fill volume (R/L), NAC and skin necrosis, and other complications requiring surgery were recorded. Postoperative photographs for NAC positioning (side view most projected point versus at a lower point) were assessed using a scoring system. Two groups were then compared.

RESULTS

Complications were higher in the non-Duoderm® group compared with Duoderm®-bra (odds ratio, 4.5; 95% confidence interval [CI], 1.35-15.04; P = 0.021). Optimum nipple positioning was significantly higher with Duoderm®-bra compared with no Duoderm®-bra (odds ratio, 50.0; 95% CI, 10.9-230.1; P < 0.0001). There was no difference in timing from mastectomy to completion of expansion in the Duoderm® group compared with no Duoderm®-bra group (mean difference, -2.35; 95% CI, -10.37 to 5.68).

CONCLUSIONS

Use of "Duoderm®-bra" without intraoperative tissue expansion in NSM is a new technique. This technique improves nipple position with less ptosis and greater elevation, decreases flap and NAC necrosis complications, and does not increase total reconstructive period in NSM patients.

摘要

背景

保留乳头的乳房切除术(NSM)联合组织扩张器重建是一种广泛应用的技术,乳房切除术后可产生美观的重建效果。乳头位置以及血运良好的健康乳房切除皮瓣是获得理想美学最终效果的重要决定因素。扩张器初始高填充量可使术后乳房外形更自然。然而,这常常会导致缺血,进而乳头乳晕复合体(NAC)丧失。相反,术中低填充率有利于增强组织循环和活力。但这可能导致皮肤包膜下垂及乳头位置低于预期。我们研发了一种名为“Duoderm®胸罩”的新技术,该技术将乳房切除皮肤组织的健康状况与乳头最佳定位的美学成功相结合。我们假设使用Duoderm®胸罩可使NAC稳定在理想的高位并减少下垂。我们还假设通过无需脱细胞真皮基质和术中填充,“Duoderm®胸罩”将降低并发症发生率。本研究的目的是评估在NSM中使用新型“Duoderm®胸罩”技术的效果。

方法

经机构审查委员会批准后,对35例连续患者进行回顾性病历审查,这些患者共65侧乳房由同一位整形外科医生进行NSM和组织扩张器重建。将使用“Duoderm®胸罩”的患者与未使用“Duoderm®胸罩”的患者进行比较。排除使用脱细胞真皮基质的患者。记录年龄、下垂分级、术前乳头至乳房下皱襞比例(右/左)、肿瘤特征、乳房切除标本重量(右/左)、从乳房切除到首次填充的时间、从乳房切除到最终填充的时间、最终填充量(右/左)、NAC和皮肤坏死情况以及其他需要手术的并发症。使用评分系统评估术后NAC定位的照片(侧视图中最突出点与较低点)。然后对两组进行比较。

结果

与Duoderm®胸罩组相比,非Duoderm®组的并发症更高(优势比,4.5;95%置信区间[CI],1.35 - 15.04;P = 0.021)。与未使用Duoderm®胸罩相比,使用Duoderm®胸罩时乳头最佳定位显著更高(优势比,50.0;95% CI,10.9 - 230.1;P < 0.0001)。与未使用Duoderm®胸罩组相比,Duoderm®组从乳房切除到扩张完成的时间无差异(平均差异, - 2.35;95% CI, - 10.37至5.68)。

结论

在NSM中不进行术中组织扩张而使用“Duoderm®胸罩”是一种新技术。该技术可改善乳头位置,减少下垂并提高提升效果,降低皮瓣和NAC坏死并发症,且不会增加NSM患者的总重建时间。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验